Structure-Based Methods for Predicting the Sites and Products of Metabolism

Drug Metabolism Prediction

Volumn , Issue , 2014, Pages 243-264

  Oostenbrink, Chris ^a  

^a UNIVERSITY OF NATURAL RESOURCES AND LIFE SCIENCES   (Austria)

Author keywords

Cytochrome P450; Docking; Mutation; Protein flexibility; Site of metabolism prediction; Solvation

Indexed keywords

EID: 84926404059     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9783527673261.ch10     Document Type: Chapter

References (74)

1. De Groot, M.J., Kirton, S.B., and Sutcliffe, M.J. (2004) In silico methods for predicting ligand binding determinants of cytochromes P450. Current Topics in Medicinal Chemistry, 4, 1803-1824.
2. De Graaf, C., Vermeulen, N.P.E., and Feenstra, K.A. (2005) Cytochrome P450 in silico: an integrative modeling approach. Journal of Medicinal Chemistry, 48, 2725-2755.
3. Stjernschantz, E., Vermeulen, N.P.E., and Oostenbrink, C. (2008) Computational prediction of drug binding and rationalisation of selectivity towards cytochromes P450. Expert Opinion on Drug Metabolism & Toxicology, 4, 513-527.
4. Kirchmair, J., Williamson, M.J., Tyzack, J.D., Tan, L., Bond, P.J., Bender, A., and Glen, R.C. (2012) Computational prediction of metabolism: sites, products, SAR, P450 enzyme dynamics, and mechanisms. Journal of Chemical Information and Modeling, 52, 617-648.
5. Groenhof, A.R., Ehlers, A.W., and Lammertsma, K. (2007) Oxygen-oxygen bond splitting mechanism in cytochrome P450. Journal of the American Chemical Society, 129, 6204-6209.
6. Vasanthanathan, P., Taboureau, O., Oostenbrink, C., Vermeulen, N.P.E., Olsen, L., and Jorgensen, F.S. (2009) Classification of cytochrome P450 1A2 inhibitors and non-inhibitors by machine learning techniques. Drug Metabolism and Disposition, 37, 658-664.
7. Cruciani, G., Carosati, E., De Boeck, B., Ethirajulu, K., Mackie, C., Howe, T., and Vianello, R. (2005) MetaSite: understanding metabolism in human cytochromes from the perspective of the chemist. Journal of Medicinal Chemistry, 48, 6970-6979.
8. Afzelius, L., Hasselgren Arnby, C., Broo, A., Carlsson, L., Isaksson, C., Jurva, U., Kjellander, B., Kolmodin, K., Nilsson, K., Reaubacher, F., and Weidolf, L. (2007) State-of-the-art tools for computational site of metabolism predictions: comparative analysis, mechanistical insights, and future applications. Drug Metabolism Reviews, 39, 61-86.
9. De Graaf, C., Oostenbrink, C., Keizers, P.H.J., Van der Wijst, T., and Jongejan, A., and Vermeulen, N.P.E. (2006) Catalytic site prediction and virtual screening accuracy of cytochrome P450 2D6 substrates by consideration of water and rescoring in automated docking. Journal of Medicinal Chemistry, 49, 2417-2430.
10. Li, J., Schneebeli, S.T., Bylund, J., Farid, R., and Friesner, R.A. (2011) IDSite: an accurate approach to predict P450-mediated drug metabolism. Journal of Chemical Theory and Computation, 7, 3829-3845.
11. Rydberg, P., Gloriam, D.E., Zaretzki, J., Breneman, C., and Olsen, L. (2010) SMARTCyp: a 2D method for prediction of cytochrome P450-mediated drug metabolism. ACS Medicinal Chemistry Letters, 1, 96-100.
12. Rydberg, P. and Olsen, L. (2012) Ligand-based site of metabolism prediction for cytochrome P450 2D6. ACS Medicinal Chemistry Letters, 3, 69-73.
13. Rydberg, P. and Olsen, L. (2012) Predicting drug metabolism by cytochrome P450 2C9 - comparison to the 2D6 and 3A4 isoforms. ChemMedChem, 7, 1202-1209.
14. Oh, W.S., Kim, D.N., Jung, J., Cho, K.H., and No, K.T. (2008) New combined model for the prediction of regioselectivity in cytochrome P450/3A4 mediated metabolism. Journal of Chemical Information and Modeling, 48, 591-601.
15. Eldritch, M.D., Murray, C.W., Auton, T.R., Paolini, G.V., and Mee, R.P. (1997) Empirical scoring functions: I. The development of a fast empirical scoring function to estimate the binding affinity of ligands in receptor complexes. Journal of Computer-Aided Molecular Design, 11, 425-445.
16. Murray, C.W., Auton, T.R., and Eldritch, M.D. (1998) Empirical scoring functions: II. The testing of empirical scoring function for the prediction of ligand-receptor binding affinities and the Bayesian regression to improve the quality of the model. Journal of Computer-Aided Molecular Design, 12, 503-519.
17. Wang, R., Lai, L., and Wang, S. (2002) Further development and validation of empirical scoring functions for structure-based binding affinity prediction. Journal of Computer-Aided Molecular Design, 16, 11-26.
18. Halgren, T.A., Murphy, R.B., and Friesner, R.A. (2004) Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. Journal of Medicinal Chemistry, 47, 1750-1759.
19. Friesner, R.A., Murphy, R.B., Repasky, M.P., Frye, L.L., Greenwood, J.R., Halgren, T.A., Sanschagrin, P.C., and Mainz, D.T. (2006) Extra precision Glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. Journal of Medicinal Chemistry, 49, 6177-6196.
20. Huey, R., Morris, G.M., Olson, A.J., and Goodsell, D.S. (2007) A semiempirical free energy force field with charge-based desolvation. Journal of Computational Chemistry, 28, 1145-1152.
21. Kirton, S.B., Murray, C.W., Verdonk, M.L., and Taylor, R. (2005) Prediction of binding modes for ligands in the cytochromes P450 and other heme-containing proteins. Proteins, 58, 836-844.
22. Lexa, K.W. and Carlson, H.A. (2012) Protein flexibility in docking and surface mapping. Quarterly Reviews of Biophysics, 45, 301-343.
23. Ferrara, P., Gohlke, H., Price, D.J., Klebe, G., and Brooks, C.L., III (2004) Assessing scoring functions for protein-ligand interactions. Journal of Medicinal Chemistry, 47, 3032-3047.
24. Warren, G.L., Andrews, C.W., Capelli, A.M., Clarke, B., LaLonde, J., Lamber, M.H., Lindvall, M., Nevins, N., Semus, S.F., Senger, S., Tedesco, G., Wall, I.D., Woolven, J.M., Peishoff, C.E., and Head, M.S. (2006) A critical assessment of docking programs and scoring functions. Journal of Medicinal Chemistry, 49, 5912-5931.
25. Stjernschantz, E., Marelius, J., Medina, C., Jacobsson, M., Vermeulen, N.P.E., and Oostenbrink, C. (2006) Are automated molecular dynamics simulations and binding free energy calculations realistic tools in lead optimization? An evaluation of the linear interaction energy (LIE) method. Journal of Chemical Information and Modeling, 46, 1972-1983.
26. Karplus, M. and McCammon, J.A. (2002) Molecular dynamics simulations of biomolecules. Nature Structural Biology, 9, 646-652.
27. van Gunsteren, W.F., Bakowies, D., Baron, R., Chandrasekhar, I., Christen, M., Daura, X., Gee, P., Geerke, D., Glättli, A., Hünenberger, P.H., Kastenholz, M.A., Oostenbrink, C., Schenk, M., Trzesniak, D., van der Vegt, N.F.A., and Yu, H.B. (2006) Biomolecular modeling: goals, problems, perspectives. Angewandte Chemie, International Edition, 45, 4064-4092.
28. Beveridge, D.L. and DiCapua, F.M. (1989) Free energy via molecular simulation: applications to chemical and biomolecular systems. Annual Review of Biophysics and Biophysical Chemistry, 18, 431-492.
29. Helms, V. and Wade, R.C. (1998) Computational alchemy to calculate absolute protein-ligand binding free energy. Journal of the American Chemical Society, 120, 2710-2713.
30. Åqvist, J., Medina, C., and Samuelsson, J.E. (1994) New method for predicting binding affinity in computer-aided drug design. Protein Engineering, 7, 385-391.
31. Kollman, P.A., Massova, I., Reyes, C., Kuhn, B., Huo, S.H., Chong, L., Lee, M., Lee, T.S., Duan, Y., Wang, W., Donini, O., Cieplak, P., Srinivasan, J., Case, D.A., and Cheatham, T.E., III (2000) Calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models. Accounts of Chemical Research, 33, 889-897.
32. Sansen, S., Yano, J.K., Reynald, R.L., Schoch, G.A., Griffin, K.J., Stout, C.D., and Johnson, E.F. (2007) Adaptations for the oxidation of polycyclic aromatic hydrocarbons exhibited by the structure of human P450 1A2. The Journal of Biological Chemistry, 282, 14348-14355.
33. Jones, G., Willet, P., Glen, R.C., Leach, A. R., and Taylor, R. (1997) Development and validation of a genetic algorithm for flexible docking. Journal of Molecular Biology, 267, 727-748.
34. Vasanthanathan, P., Hritz, J., Taboureau, O., Olsen, L., Jorgensen, F.S., Vermeulen, N.P.E., and Oostenbrink, C. (2009) Virtual screening and prediction of site of metabolism for cytochrome P450 1A2 ligands. Journal of Chemical Information and Modeling, 49, 43-52.
35. Vasanthanathan, P., Olsen, L., Jorgensen, F.S., Vermeulen, N.P.E., and Oostenbrink, C. (2010) Computational prediction of binding affinity for CYP1A2-ligand complexes using empirical free energy calculations. Drug Metabolism and Disposition, 38, 1347-1354.
36. De Graaf, C., Oostenbrink, C., Keizers, P.H.J., van Vugt-Lussenburg, B.M.A., van Waterschoot, R., Tschirret-Guth, R., Commandeur, J.N.M., and Vermeulen, N.P.E. (2007) Molecular modeling-guided site-directed mutagenesis of cytochrome P450 2D6. Current Drug Metabolism, 8, 59-77.
37. Keizers, P.H.J., De Graaf, C., de Kanter, F.J.J., Oostenbrink, C., Feenstra, K.A., Commandeur, J.N.M., and Vermeulen, N.P.E. (2005) Metabolic regio- and stereoselectivity of cytochrome P450 2D6 towards 3,4-methylenedioxy-N-alkylamphetamines: in silico predictions and experimental validation. Journal of Medicinal Chemistry, 48, 6117-6127.
38. Stjernschantz, E. and Oostenbrink, C. (2010) Improved ligand-protein binding affinity predictions using multiple binding modes. Biophysical Journal, 98, 2682-2691.
39. Ekroos, M. and Sjögren, T. (2006) Structural basis for ligand promiscuity in cytochrome P450 3A4. Proceedings of the National Academy of Sciences of the United States of America, 103, 13782-13687.
40. Bren, U. and Oostenbrink, C. (2012) Cytochrome P450 3A4 inhibition by ketoconazole: tackling the problem of ligand cooperativity using molecular dynamics simulations and free-energy calculations. Journal of Chemical Information and Modeling, 52, 1573-1582.
41. Oostenbrink, C., de Ruiter, A., Hritz, J., and Vermeulen, N.P.E. (2012) Malleability and versatility of cytochrome P450 active sites studied by molecular simulations. Current Drug Metabolism, 13, 190-196.
42. Rowland, P., Blaney, F.E., Smyth, M.G., Jones, J.J., Leydon, V.R., Oxbrow, A.K., Lewis, C.J., Tennant, M.M., Modi, S., Eggleston, D.S., Chenery, R.J., and Bridges, A.M. (2005) Crystal structure of human cytochrome P450 2D6. The Journal of Biological Chemistry, 281, 7614-7622.
43. Wester, M.R., Johnson, E.F., Marques-Soares, C., Dansette, P.M., Mansuy, D., and Stout, C.D. (2003) Structure of a substrate complex of mammalian cytochrome P450 2C5 at 2.3Å resolution: evidence for multiple substrate binding modes. Biochemistry, 42, 6370-6379.
44. Williams, P.A., Cosme, J., Sridhar, V., Johnson, E.F., and McRee, D.E. (2000) Mammalian microsomal cytochrome P450 monooxygenase: structural adaptations for membrane binding and functional diversity. Molecules and Cells, 7, 121-131.
45. Hritz, J., de Ruiter, A., and Oostenbrink, C. (2008) Impact of plasticity and flexibility on docking results for cytochrome P450 2D6: a combined approach of molecular dynamics and ligand docking. Journal of Medicinal Chemistry, 51, 7469-7477.
46. Unwalla, R.J., Cross, J.B., Salaniwal, S., Shilling, A.D., Leung, L., Kao, J., and Humblet, C. (2010) Using a homology model of cytochrome P450 2D6 to predict substrate site of metabolism. Journal of Computer-Aided Molecular Design, 24, 237-256.
47. Carlson, H.A. (2002) Protein flexibility and drug design: how to hit a moving target. Current Opinion in Chemical Biology, 6, 447-452.
48. Santos, R., Hritz, J., and Oostenbrink, C. (2010) The role of water in molecular docking simulations of cytochrome P450 2D6. Journal of Chemical Information and Modeling, 10, 55-66.
49. de Beer, S.B.A., van Bergen, L.A.H., Keijzer, K., Rea, V., Venkataraman, H., Fonseca Guerra, C., Bickelhaupt, F.M., Vermeulen, N.P.E., Commandeur, J.N.M., and Geerke, D.P. (2012) The role of protein plasticity in computational rationalization studies on regioselectivity in testosterone hydroxylation by cytochrome P450 BM3 mutants. Current Drug Metabolism, 13, 155-166.
50. Moors, S.L.C., Vos, A.M., Cummings, M. D., Van Vlijmen, H., and Ceulemans, A. (2011) Structure-based site of metabolism prediction for cytochrome P450 2D6. Journal of Medicinal Chemistry, 54, 6098-6105.
51. Teixeira, V.H., Ribeiro, V., and Martel, P.J. (2010) Analysis of binding modes of ligands to multiple conformations of CYP3A4. Biochimica et Biophysica Acta, 1804, 2036-2045.
52. Wang, A., Savas, U., Hsu, M.H., Stout, C.D., and Johnson, E.F. (2012) Crystal structure of human cytochrome P450 2D6 with prinomastat bound. The Journal of Biological Chemistry, 287, 10834-10843.
53. Dunitz, J.D. (1994) The entropic cost of bound waters in crystals and biomolecules. Science, 264, 670.
54. Karplus, M. and Faerman, C. (1994) Ordered water in macromolecular structure. Current Opinion in Structural Biology, 4, 770-776.
55. de Beer, S.B.A., Vermeulen, N.P.E., and Oostenbrink, C. (2010) The role of water molecules in computational drug design. Current Topics in Medicinal Chemistry., 10, 55-66.
56. Kirchmair, J., Spitzer, G.M., and Liedl, K.R. (2011) Consideration of water and solvation effects in virtual screening, in Virtual Screening - Methods and Principles in Medicinal Chemistry (ed. C.A. Sotriffer), Wiley-VCH Verlag GmbH, Weinheim, pp. 263-290.
57. cam. Proteins, 32, 381-396.
58. Poulos, T.L., Finzel, B.C., and Howard, A.J. (1986) Crystal structure of substrate free Pseudomonas putida cytochrome P450. Biochemistry, 25, 5314-5322.
59. cam. Journal of Molecular Biology, 195, 687-700.
60. cam: a molecular dynamics study. Biophysical Journal, 69, 810-824.
61. Verdonk, M.L., Chessari, G., Cole, J.C., Hartshorn, M.J., Murray, C.W., Nissink, J.W.M., Taylor, R.D., and Taylor, R. (2005) Modeling water molecules in protein-ligand docking using GOLD. Journal of Medicinal Chemistry, 48, 6504-6415.
62. De Graaf, C., Pospisil, P., Pos, W., Folkers, G., and Vermeulen, N.P.E. (2005) Binding mode prediction of cytochrome P450 and thymidine kinase protein-ligand complexes by consideration of water and rescoring in automated docking. Journal of Medicinal Chemistry, 48, 2308-2318.
63. Venhorst, J., ter Laak, A.M., Commandeur, J.N.M., Funae, Y., Hiroi, T., and Vermeulen, N.P.E. (2003) Homology modeling of rat and human cytochrome P450 2D (CYP 2D) isoforms and computational rationalisation of experimental ligand-binding specificities. Journal of Medicinal Chemistry, 46, 74-86.
64. Vermeulen, N.P.E. (2003) Prediction of drug metabolism: the case of cytochrome P450 2D6. Current Topics in Medicinal Chemistry., 3, 1227-1239.
65. De Graaf, C., Oostenbrink, C., Keizers, P.H.J., van Vugt-Lussenburg, B.M.A., Commandeur, J.N.M., and Vermeulen, N.P.E. (2007) Free energies of binding of R- and S-propranolol to wildtype and F483A mutant cytochrome P450 2D6 from molecular dynamics simulations. European Biophysics Journal, 36, 589-599.
66. Nagy, G. and Oostenbrink, C. (2012) Rationalization of stereospecific binding of propranolol to cytochrome P450 2D6 by free energy calculations. European Biophysics Journal, 41, 1065-1076.
67. Guengerich, F.P. (2002) Cytochrome P450 enzymes in the generation of commercial products. Nature Reviews. Drug Discovery, 1, 359-366.
68. Urlacher, V.B., Lutz-Wahl, S., and Schmid, R.D. (2004) Microbial P450 enzymes in biotechnology. Applied Microbiology and Biotechnology, 64, 317-325.
69. van Vugt-Lussenburg, B.M.A., Damsten, M.C., Maasdijk, D.M., Vermeulen, N.P.E., and Commandeur, J.N.M. (2006) Heterotropic and homotropic cooperativity by a drug-metabolising mutant of cytochrome P450 BM3. Biochemical and Biophysical Research Communications, 346, 810-818.
70. Geier, M., Braun, A., Fladischer, P., Stepniak, P., Rudroff, F., Hametner, C., Mihovilovic, M.D., and Glieder, A. (2013) Double site saturation mutagenesis of the human cytochrome P450 2D6 results in regioselective steroid hydroxylation. FEBS Journal, 280, 3094-3108.
71. Stjernschantz, E., van Vugt-Lussenburg, B.M.A., Bonifacio, A., de Beer, S.B.A., van der Zwan, G., Gooijer, C., Commandeur, J.N.M., Vermeulen, N.P.E., and Oostenbrink, C. (2008) Structural rationalization of novel drug metabolizing mutants of cytochrome P450 BM3. Proteins, 71, 336-352.
72. van Vugt-Lussenburg, B.M.A., Stjernschantz, E., Lastdrager, J., Oostenbrink, C., Vermeulen, N.P.E., and Commandeur, J.N.M. (2007) Identification of novel critical residues in drug metabolising mutants of cytochrome P450 BM3 using random mutagenesis. Journal of Medicinal Chemistry, 50, 455-461.
73. Venkataraman, H., de Beer, S.B.A., Geerke, D.P., Vermeulen, N.P.E., and Commandeur, J.N.M. (2012) Regio- and stereoselective hydroxylation of optically active alpha-ionone enantiomers by engineered cytochrome P450 BM3 mutants. Advanced Synthesis and Catalysis, 354, 2172-2184.
74. de Beer, S.B.A., Venkataraman, H., Geerke, D., and Oostenbrink, C. (2012) Free energy calculations give insight into the stereoselective hydroxylation of α-ionones by engineered cytochrome P450 BM3 mutants. Journal of Chemical Information and Modeling, 52, 2139-2148.